Package Leaflet: Information for the User
ZYPREXA 2.5 mg film-coated tablets
ZYPREXA 5 mg film-coated tablets
ZYPREXA 7.5 mg film-coated tablets
ZYPREXA 10 mg film-coated tablets
ZYPREXA 15 mg film-coated tablets
ZYPREXA 20 mg film-coated tablets
olanzapine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
ZYPREXA contains the active substance olanzapine. ZYPREXA belongs to a group of medicines called antipsychotics and is used to treat the following conditions:
ZYPREXA has been shown to prevent the recurrence of these symptoms in patients with bipolar disorder whose manic episodes have responded to treatment with olanzapine.
Do not take ZYPREXA
Warnings and precautions
Consult your doctor or pharmacist before starting to take ZYPREXA.
If you suffer from any of the following diseases, tell your doctor as soon as possible:
If you suffer from dementia, you or your caregiver or family member should inform your doctor if you have ever had a stroke or a lack of blood flow to the brain.
As a routine precaution, if you are over 65 years old, it would be advisable for your doctor to check your blood pressure.
Children and adolescents
Patients under 18 years of age should not take ZYPREXA.
Other medicines and ZYPREXA
Only use other medicines at the same time as ZYPREXA if your doctor authorizes it. You may feel drowsy if you combine ZYPREXA with antidepressants or medications for anxiety or that help you sleep (tranquilizers).
Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.
In particular, tell your doctor if you are taking:
Using ZYPREXA with alcohol
You should not drink alcohol if you have been given ZYPREXA, as it may cause drowsiness.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine. You should not take this medicine when you are breastfeeding, as small amounts of ZYPREXA can pass into breast milk.
The following symptoms may occur in newborns of mothers who have used ZYPREXA in the last trimester (last three months of pregnancy): tremors, muscle stiffness and/or weakness, drowsiness, agitation, breathing problems, and difficulty feeding. If your baby has any of these symptoms, contact your doctor.
Driving and using machines
There is a risk of drowsiness when taking ZYPREXA. If this happens, do not drive vehicles or use machinery. Consult your doctor.
ZYPREXA contains lactose
If your doctor has told you that you have an intolerance to some sugars, consult your doctor before taking this medicine.
Follow exactly the administration instructions of this medicine given by your doctor. In case of doubt, consult your doctor or pharmacist again.
Your doctor will tell you how many ZYPREXA tablets to take and for how long. The daily dose of ZYPREXA ranges from 5 mg to 20 mg. Consult your doctor if you experience symptoms again, but do not stop taking ZYPREXA unless your doctor tells you to.
You should take your ZYPREXA tablets once a day, following your doctor's instructions. Try to take the tablets at the same time every day. You can take them with or without food. ZYPREXA film-coated tablets are for oral administration. You should swallow the ZYPREXA tablets whole with water.
If you take more ZYPREXA than you should
Patients who have taken more ZYPREXA than they should have experienced the following symptoms: rapid heartbeat, agitation/aggression, speech problems, unusual movements (especially of the face and tongue), and a reduced level of consciousness. Other symptoms may include: acute confusion, seizures (epilepsy), coma, a combination of fever, rapid breathing, sweating, muscle stiffness, and a state of confusion or drowsiness, slowing of respiratory rate, aspiration, increased or decreased blood pressure, and abnormal heart rhythms. Contact your doctor or go to the hospital immediately if you notice any of the above symptoms. Show the doctor the package with the tablets.
If you forget to take ZYPREXA
Take your tablets as soon as you remember. Do not take a double dose to make up for forgotten doses.
If you stop taking ZYPREXA
Do not stop treatment just because you feel better. It is very important that you continue taking ZYPREXA while your doctor tells you to.
If you stop taking ZYPREXA suddenly, you may experience symptoms such as sweating, insomnia, tremors, anxiety, or nausea and vomiting. Your doctor may suggest that you gradually reduce the dose before stopping treatment.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Contact your doctor immediately if you have:
Very common side effects (which can affect more than 1 in 10 people) include weight gain; drowsiness; and increased prolactin levels in the blood. In the early stages of treatment, some people may feel dizzy or faint (with slower heartbeats), especially when getting up from a lying or sitting position. This feeling usually goes away on its own, but if it does not, consult your doctor.
Common side effects (which can affect up to 1 in 10 people) include changes in the levels of some blood cells, circulating lipids, and temporary increases in liver enzymes at the start of treatment; increased blood sugar and urine levels; increased uric acid and creatine phosphokinase levels in the blood; increased appetite; dizziness; agitation; tremors; unusual movements (dyskinesia); constipation; dry mouth; skin rash; loss of strength; excessive fatigue; fluid retention that causes swelling of the hands, ankles, or feet; fever; joint pain; and sexual dysfunctions such as decreased libido in men and women or erectile dysfunction in men.
Rare side effects (which can affect up to 1 in 100 people) include hypersensitivity (e.g., inflammation of the mouth and throat, itching, skin rash); diabetes or worsening of diabetes, occasionally related to ketoacidosis (acetone in blood and urine) or coma; seizures, most often related to a history of seizures (epilepsy); muscle stiffness or spasms (including eye movements); restless legs syndrome; speech problems; stuttering; slow pulse; sensitivity to sunlight; nosebleeds; abdominal distension; excessive salivation; memory loss or forgetfulness; urinary incontinence; loss of urination ability; hair loss; absence or decrease of menstrual periods; and changes in the mammary gland in men and women, such as abnormal milk production or abnormal growth.
Very rare side effects (which can affect up to 1 in 1000 people) include a drop in normal body temperature; abnormal heart rhythm; sudden unexplained death; pancreatitis, which causes severe stomach pain, fever, and discomfort; liver disease, with yellowing of the skin and the white parts of the eyes; muscle disorder that presents as unexplained pain and prolonged and/or painful erections.
Very rare side effects include severe allergic reactions such as drug reaction with eosinophilia and systemic symptoms (DRESS). Initially, DRESS is manifested with symptoms similar to the flu, with a rash on the face, and later with an extensive rash, fever, swollen lymph nodes, elevated liver enzymes observed in blood tests, and an increase in a type of white blood cell (eosinophilia).
During treatment with olanzapine, elderly patients with dementia may experience stroke, pneumonia, urinary incontinence, falls, extreme fatigue, visual hallucinations, a rise in body temperature, skin redness, and walking problems. Some deaths have been reported in this particular group of patients.
ZYPREXA may worsen symptoms in patients with Parkinson's disease.
Reporting of side effects
If you experience any side effects, talk to your doctor or nurse, even if they are not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton.
ZYPREXA should be stored in the original package to protect it from light and moisture.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of ZYPREXA
CONCENTRATION | OTHER INGREDIENTS |
ZYPREXA 2.5 mg, 5 mg, 7.5 mg, and 10 mg tablets | (tablet coating) shellac, macrogol, propylene glycol, polysorbate 80, and carmine indigo (E132), anhydrous ethanol, isopropyl alcohol, butyl alcohol, ammonia hydroxide |
ZYPREXA 15 mg tablets | (tablet coating) triacetin and carmine indigo (E132). |
ZYPREXA 20 mg tablets | (tablet coating) macrogol and synthetic red iron oxide (E172) |
Appearance and packaging
ZYPREXA 2.5 mg film-coated tablets are white and have "LILLY" and a numerical identification code "4112" printed on them.
ZYPREXA 5 mg film-coated tablets are white and have "LILLY" and a numerical identification code "4115" printed on them.
ZYPREXA 7.5 mg film-coated tablets are white and have "LILLY" and a numerical identification code "4116" printed on them.
ZYPREXA 10 mg film-coated tablets are white and have "LILLY" and a numerical identification code "4117" printed on them.
ZYPREXA 15 mg film-coated tablets are blue.
ZYPREXA 20 mg film-coated tablets are pink.
ZYPREXA is available in packs of 28, 35, 56, 70, or 98 tablets. Not all pack sizes may be marketed.
Marketing authorization holder:
CHEPLAPHARM Registration GmbH, Weiler Straße 5e, 79540 Lörrach, Germany.
Manufacturer
Lilly S.A., Avda. de la Industria 30, 28108 Alcobendas, Madrid, Spain.
Fidelio Healthcare Limburg GmbH, Mundipharmastraße 2, 65549 Limburg an der Lahn, Germany.
CHEPLAPHARM Registration GmbH, Weiler Straße 5e, 79540 Lörrach, Germany.
Date of last revision of this leaflet:
Detailed information on this medicine is available on the European Medicines Agency website http://www.ema.europa.eu/.